3Zhang X, Chen Z, Choe M S, et al. Tumor growth inhibition by simeltaneously blocking Epidermal Growth Factor Receptor and cyclooxygenase - 2 in a xenograft model. Clin Cancer Res , 2005,11 ( 17 ) :6261.
4Julie G, Jaffer A. Thinking in and out of the box when it comes to gastric cancer and cyclooxygenase- 2. J Clin Oncol,2007,25 (31):4865.
5Han C, Michalopoulos G K, Wu T. Prostaglandin E2 receptor EP1 trans - activates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. Cell Physiol,2006, 207(1) : 261.
6Huang L,Wang C ,Zheng W,et al. Effects of celeeoxib on the reversal of mutidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P -glycoprotein. Anticancer Drugs,2007, 18 (9) :1075.
8Khuri FR, Wu H, Lee JJ, et al. Cycloxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer [ J]. Clin Cancer Res, 2001,7(4) : 861 -867.
9Laga AC, Zander DS, Cagle PT, et al. Prognostic significance of cyclooxygenase-2 expression in 259 cases of non-small cell lung cancer [J]. Arch Pathol Lab Med, 2005,129(9) :1113 -1117.
10Arber N. Cyclooxygenase-2 inhibitors in colorectal cancer prevention : point [ J]. Cancer Epidemiol Biomarkers Prev,2008, 17 (8) : 1852 - 1857.
